The Moat Index

BioLife Solutions, Inc.

BLFS · Healthcare · $1.4B mkt cap · FY2025 filings · Shallow moat ·

Doesn't clear the bar

46/ 100
Shallow moat

The four filters

Pricing power96

Median gross margin 64.6% over 7y, very stable.

Returns on capital4

Median ROIC -3.8%, above the 9% hurdle in 11% of years.

Balance-sheet safety55

Net cash position — no leverage risk.

Capital discipline24

Owner earnings trend unclear, share count growing (dilution).

Margin of safety

Above valueOn sale
No price data
Owner earnings (normalized)
Est. intrinsic value / share
Recent price
$29.15
Discount to value
No price data

Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

17 years of fundamentals

The business, in plain English

BioLife Solutions, Inc. booked $96.2M of revenue in FY2025 in the Healthcare sector and kept 64.6% of it as gross profit — a high-margin business by that measure. After every other cost, −4.8% of each revenue dollar reached the bottom line.

Across the filed record, revenue grew from $2.1M (FY2010) to $96.2M (FY2025) — about 29.1% a year compounded over 15 years.

It earned −3.8% on invested capital in FY2025, with a median of −4.1% across 11 filed years. The Returns on Capital filter above scores it 4/100.

The balance sheet carried $5.0M of total debt in FY2025. Balance-Sheet Safety scores it 55/100.

The share count fell 30.8% between FY2010 and FY2025 — management has been retiring shares, which concentrates each remaining owner's claim. Capital Discipline scores it 24/100.

Put together: Pricing Power is the strongest of the four filters (96/100) and Returns on Capital the weakest (4/100), which is how BLFS lands at 46/100 — a Shallow moat.

This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.

FY2009–FY2025 · 17 fiscal years, normalized from BLFS’s SEC filings

RevenueSales, as filed$96.2M FY2025
$0$50M$100M2009201520212025
Gross marginRevenue kept after cost of goods64.6% FY2025
0%25%50%2009201520212025
Return on invested capitalOperating profit on the capital employed−3.8% FY2025
−50%0%2009201520212025
Owner earningsCash an owner could take out−$4.6M FY2025
−$100M$02009201520212025

Gaps in a line mean that item isn’t in BLFS’s filings for that year — the series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.

Moat Score history

3 logged readings since Jul 17, 2026 · append-only, never rewritten

Moat Score over timeLast scored reading of each day, on the 0–100 scale45.8 / 100
0406080100WideNarrowShallowNo moatJul 17, 2026

Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — BLFS has read Shallow moat for every logged capture since Jul 17, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Healthcare context

#158 of 440 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

  1. #156ITRI Itron, Inc.45.9 out of 100, Shallow moatShallow moat
  2. #157SRTS Sensus Healthcare, Inc.45.9 out of 100, Shallow moatShallow moat
  3. #159IBRX IMMUNITYBIO, INC.45.8 out of 100, Shallow moatShallow moat
  4. #160RARE Ultragenyx Pharmaceutical Inc.45.8 out of 100, Shallow moatShallow moat

Compare BLFS with its nearest peersAll Healthcare companies on the Index →

Common questions about BLFS

Does BioLife Solutions, Inc. have an economic moat?
Based on its FY2025 SEC filings, the Moat Index scores BioLife Solutions, Inc. (BLFS) 45.8 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 96, returns on capital 4, balance-sheet safety 55, capital discipline 24.
How has BLFS's Moat Score changed over time?
The record logs 3 readings since Jul 17, 2026; the latest reads 45.8 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.
Embed this score on your site

One iframe, no script. The badge shows BLFS’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/BLFS"
  width="340" height="150" style="border:0"
  title="BLFS Moat Score — The Moat Index"
  loading="lazy"></iframe>
BioLife Solutions, Inc. (BLFS) Moat Score — The Moat Index · Buy Like Buffett